INCREASED SERUM ALPHA(1)-ANTICHYMOTRYPSIN IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE - AN ACUTE-PHASE REACTANT WITHOUT THE PERIPHERAL ACUTE-PHASE RESPONSE
F. Licastro et al., INCREASED SERUM ALPHA(1)-ANTICHYMOTRYPSIN IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE - AN ACUTE-PHASE REACTANT WITHOUT THE PERIPHERAL ACUTE-PHASE RESPONSE, Journal of neuroimmunology, 57(1-2), 1995, pp. 71-75
Serum levels of alpha(1)-antichymotrypsin (alpha(1)-ACT) were measured
in patients with early and late onset Alzheimer's disease (e-AD, I-AD
), patients with vascular dementia (VD) and healthy elderly. Patients
with I-AD were divided into two groups, one had normal alpha(1)-ACT va
lues and one had increased serum levels of alpha(1)-ACT. Other acute p
hase proteins were also measured. The serum levels of alpha(2)-macrogl
obulin (alpha(2)-MG), alpha(1)-antitrypsin (alpha(1)-AT), ceruloplasmi
n (CER), transferrin (TRSF) and alpha(1)-acid glycoprotein (alpha(1)-a
c.GL) were within the normal range. The C reactive protein (CRP) was o
ccasionally detectable at low concentrations in e-AD, in both groups o
f I-AD patients and in VD patients. Low serum concentrations of interl
eukin-6 (IL-6) were found in a higher proportion of I-AD than in patie
nts with e-AD or VD. These results indicated that increased levels of
alpha(1)-ACT along with occasional detection of IL-6 might be peripher
al markers of the 'acute reaction' in the brain.